Gross Paul Edward 4
4 · Clovis Oncology, Inc. · Filed Sep 6, 2022
Insider Transaction Report
Form 4
Gross Paul Edward
See Remarks
Transactions
- Sale
Common Stock
2022-09-02$1.20/sh−2,308$2,770→ 92,812 total - Exercise/Conversion
Restricted Stock Units
2022-09-01+5,063→ 50,625 total→ Common Stock (5,063 underlying) - Exercise/Conversion
Common Stock
2022-09-01+5,063→ 95,120 total
Footnotes (3)
- [F1]Each Restricted Stock Unit represents the right to receive one share of Common Stock.
- [F2]Represents the shares automatically sold by the reporting person pursuant to an election to satisfy tax withholding obligations in connection with the vesting of the Restricted Stock Units listed in Table II. This sale does not represent a discretionary trade by the reporting person.
- [F3]On March 1, 2021, the reporting person was granted 81,000 Restricted Stock Units. 25% of such Restricted Stock Units vested on March 1, 2022, and the remainder vests in substantially equal installments over the 12 quarters immediately following such date.